ArticleMedicina (Kaunas, Lithuania)2025

Efficacy and Clinical Outcomes of Crizotinib in Patients with ROS1-Rearranged NSCLC: A Multicenter Study.

Alper Topal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.